Partner`s Leukine® Receives Approval in Japan to Treat aPAP
03 Apr 2024 //
PR NEWSWIRE
Review Highlights Importance of Leukine with Anti-GD2 Immunotherapy
17 Jan 2024 //
PR NEWSWIRE
Results Suggest the Potential Role of LEUKINE as a Host-Directed Immunomodulator
20 Dec 2023 //
PR NEWSWIRE
Partner Therapeutics Announces Publication of a Retrospective Cohort Review
15 Dec 2022 //
PRNEWSWIRE
Partner Tx to Publish Results from PC Study Evaluating Recombinant Murine GM-CSF
29 Mar 2022 //
PRNEWSWIRE
Tanner Pharma Increases Europe-Based Inventory of Leukine
24 Mar 2022 //
BUSINESSWIRE
BARDA and Partner Therapeutics foster a new partnership around Leukine
20 Sep 2021 //
PRNEWSWIRE
Enforcement Report - Week of July 21, 2021
21 Jul 2021 //
FDA
Partner Therapeutics Announces Publication of Clinical Trial Results of Leukine®
18 May 2021 //
PARTNERTX
Partner Initiates Patient Enrollment in Clinical Trial Evaluating Leukine®
29 Apr 2021 //
PRNEWSWIRE
Partner Initiates Patient Enrollment in Clinical Trial Evaluating Leukine®
29 Apr 2021 //
PRNEWSWIRE
Partner Announces Publication of Clinical Trial Results Showing Benefit
25 Mar 2021 //
BIOSPACE
Partner Therapeutics Announces Publication of Clinical Trial Results
24 Mar 2021 //
PRNEWSWIRE
Partner Therapeutics Announces Partnership with SIRS Therapeutics and F4 Pharma
03 Mar 2021 //
PRNEWSWIRE
Partner Therapeutics’ inhaled sargramostim improves lung function in trial
01 Mar 2021 //
CLINICALTRIALSARENA
SARPAC Clinical Trial of Leukine® (sargramostim, rhu GM-CSF) in Hospitalized
26 Feb 2021 //
PRNEWSWIRE
Partner Therapeutics Announces Publication of Two Studies Leukine®
18 Feb 2021 //
PRNEWSWIRE
Partner Therapeutics (PTx) Appints Ed Rock as Chief Medical Officer
15 Sep 2020 //
PRNEWSWIRE
Partner Initiates Patient Enrollment in U.S. Trial Evaluating Leukine®
25 Aug 2020 //
PRNEWSWIRE
Partner Announces $35 M Contract with U.S. Department of Defense of Leukine®
04 Aug 2020 //
PRNEWSWIRE
Partner begins phase II study of Leukine in T cell replete HLA-mismatched
12 Jun 2020 //
PHARMABIZ
Partner Therapeutics Announces Initiation of Clinical Trial Evaluating Leukine®
10 Jun 2020 //
PRNEWSWIRE